[144] LifeMD, Inc. 8.875% Series A Cumulative Perpetual Preferred Stock SEC Filing

Rhea-AI Filing Summary

Form 144 notice for proposed sale of securities. The filer intends to sell 75,000 common shares of the issuer through Charles Schwab (3000 Schwab Way, Westlake, TX) on 09/10/2025 on NASDAQ, with an aggregate market value of $459,000. The issuer has 47,417,393 shares outstanding. The 75,000 shares were acquired by RSU vesting from the issuer on 03/01/2025. No securities were sold by the selling person during the past three months. The notice includes the seller's representation that they possess no undisclosed material adverse information.

Insights

Securities Analyst

TL;DR: Routine insider sale paperwork documenting RSU vesting and a scheduled market sale of 75,000 shares.

The filing is a standard Form 144 showing an insider or related person selling shares that were recently acquired via RSU vesting. The planned sale size (75,000 shares, $459,000) represents approximately 0.16% of the reported 47.4 million shares outstanding, so the transaction is unlikely to be materially dilutive or to by itself shift market valuation. The record that there were no sales in the prior three months and that acquisition occurred by RSU vesting are consistent with routine compensation monetization rather than an accelerated divestiture.

Compliance Officer

TL;DR: Filing appears procedurally complete for Rule 144 disclosure; includes required representations.

The notice contains the core Rule 144 elements: class of securities, broker details, amount, market value, outstanding shares, acquisition method and date, and an explicit representation regarding material nonpublic information. The absence of prior sales in the last 3 months simplifies aggregation rules. There is no indication in this document of a 10b5-1 trading plan adoption date; if applicable, that detail is not provided here.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Charles Schwab Corp. 3000 Schwab Way Westlake TX 76262	75000	459000.00	47417393	09/10/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/01/2025	RSU Vesting	Issuer			75000	03/01/2025	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What securities does the Form 144 for LFMDP report?

The notice reports the proposed sale of 75,000 common shares of the issuer.

When and where is the proposed sale scheduled?

The sale is scheduled for 09/10/2025 on NASDAQ through Charles Schwab.

How were the shares acquired that are proposed for sale?

The 75,000 shares were acquired by RSU vesting from the issuer on 03/01/2025.

What is the aggregate market value and the issuer's outstanding shares?

Aggregate market value is listed as $459,000 and outstanding shares are 47,417,393.

Has the seller made other sales in the past three months?

The filing states Nothing to Report for securities sold during the past three months.

Does the filing state whether the seller has material nonpublic information?

Yes. By signing, the seller represents they do not know any material adverse information about the issuer that is not publicly disclosed.